Protective effect of Butea monosperma on high-fat diet and streptozotocin-induced nongenetic rat model of type 2 diabetes: Biochemical and histological evidences

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 3, 2011, Pages 74-81

  Parveen, Kehkashan ^a   Siddiqui, Waseem Ahmad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Butea monosperma; Hyperglycemia; Hyperlipidemia; Oxidative damage; Type 2 diabetes mellitus

Indexed keywords

ANTIOXIDANT; CATALASE; FATTY ACID; GLUCOSE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BUTEA; BUTEA MONOSPERMA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; FLOWER; GLUCOSE BLOOD LEVEL; HISTOLOGY; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID DIET; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PROTEIN CARBONYLATION; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79960801303     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14.
2. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-1828.
3. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
4. Green J, Feinglos M. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm. Int J Clin Pract Suppl 2007; 61: 3-11.
5. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol 2006; 24: 237-246.
6. Plumbo PJ. Glycemic control, mealtime glucose excursions and diabetic complications in type 2 diabetes mellitus. Mayo Clin Proc 2001; 76: 609-618.
7. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40: 163-73.
8. Burlia DA, Khadeb AB. A Comprehensive review on Butea monosperma (Lam.) Kuntze. Pharmacognosy Rev 2007; 1: 333-337.
9. Somani R, Kasture S, Singhai AK, Antidiabetic potential of Butea monosperma in rats. Fitoterapia, 77 (2): 86-90, (2006).
10. Sharmna N, Garg V. Antihyperglycemic and antioxidative potential of hydroalcoholic extract of Butea monosperma Lam flowers in alloxan-induced diabetic mice. Indian J Exp Biol 2009; 47: 571-576.
11. Panda S, Jafri M, Kar A, Mehet BK. Thyroid inhibitory, antiperoxidative and hypoglycemic effects of stigmasterol isolated from Butea monosperma. Fitoterapia 2009; 80: 123-126.
12. Bavarva JH, Narasimhacharya AV. Preliminary study on antihyperglycemic and antihyperlipaemic effects of Butea monosperma in NIDDM rats. Fitoterapia 2008; 79: 328-331.
13. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000; 49: 1390-1394.
14. Kokate CK, Purohit CK, Gokhale SB. Phytochemical tests. In: pharmacognosy, Nirali Prakashan; Pune, India, 1996. p.510-2.
15. Falholt K, Falholt WN, Lund B. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin Chim Acta 1973; 46: 105-111.
16. Utley HC, Bernheim F, Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 1967; 118: 521-531.
17. Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
18. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzeneinduced liver necrosis: Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151-169.
19. Habig WH, Pabst M, Jakoby WB. Glutathion-S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
20. Claiborne A. Catalase activity. In: Green Wald RA, editors. CRC handbook of methods for oxygen radical research. CRC Press Boca Raton: FL; 1985. p.283-4.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Sehrawat A, Khan TH, Prasad L, Sultana S. Butea monosperma and chemomodulation: protective role against thioacetamidemediated hepatic alterations in Wistar rats. Phytomedicine 2006; 13: 157-163.
23. Rice-Evans C, Sampson J, Bramley PM, Holloway DE. Why do we expect carotenoids to be antioxidants in vivo. Free Radic Res 1997; 26: 381-398.
24. Jorgensen LV, Madsen HL, Thomsen MK, Dragsted LO, Skibsted LH. Regulation of phenolic antioxidants from phenoxyl radicals: An ESR and electrochemical study of antioxidant hierarchy. Free Radic Res 1999; 30: 207-220.
25. Grover JK, Vats V, Rathi SS. Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 2000; 73: 461-470.
26. Ravi K, Ramachandran B, Subramanian S. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats. Life Sci 2004; 75: 2717-2731.
27. Sathishsekar D, Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol Pharm Bull 2005; 28: 978-983.
28. Goldstein DE. How much do you know about glycated hemoglobin testing. Clin Diabet 1995; 13: 60-63.
29. Goldberg RB. Lipid disorders in diabetes. Diabetes care 1981; 4: 561-572.
30. Choy CK, Rodgers JE, Nappi JM, Haines ST. Type 2 diabetes mellitus and heart failure. Pharmacotherapy 2008; 28: 170-192.
31. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983; 52: 711-760.
32. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283.
33. Berlett BS, Stadtman ER, Protein oxidation in ageing, disease and oxidative stress. J Biol Chem 1997; 272: 20313-20316.
34. Tana BKH, Tanb CH, Pushparaj PN. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sci 2005; 76: 2827-239.
35. Kaviarasan K, Pugalendi KV. Influence of flavonoid-rich fraction from Spermacoce hispida seed on PPAR-alpha gene expression, antioxidant redox status, protein metabolism and marker enzymes in high-fat-diet fed STZ diabetic rats. J Basic Clin Physiol Pharmacol 2009; 20: 141-158.
36. Yoon JW, Jun HS. Autoimmune destruction of pancreatic betacells. Am J Ther 2005; 12: 580-591.
37. Ortis F, Cardozo AK, Crispim D, Storling J, Mandrup-Poulsen T, Eizirik DL. Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-kappaB activation. Mol Endocrinol 2006; 20: 1867-79.
38. Schreck S, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Radic Res Commun 1992; 17: 221-237.
39. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP. The role of oxidative stress and NF-B activation in late diabetic complications. Biofactors 1999; 10 (2-3): 157-167.
40. Rasheed Z, Akhtar N, Khan A, Khan KA, Haqqi TM. Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8. J Pharmacol Exp Ther 2010; 333: 354-63.
41. George F, Zohar K, Harinder PS, Makkar Klaus B. The biological action of saponins in animal systems: a review. Brit J Nutr 2002; 88: 587-605.
42. Augustin S, Ian TJ, Mike S. Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005; 81: 215S-217S.